Back to results
US 2024/0174995 A1Published application
System and method for genome editing based on c2c1 nucleases
AssigneeInstitute of Zoology, Chinese Academy of Sciences
InventorsWei Li, Qi Zhou, Fei Teng
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of genetic engineering. In particular, the present invention relates to a genome editing system and method based on C2c1 nuclease. The present invention also relates to artificial guide RNA which can be combined with the C2c1 nuclease and used for genomic editing
Claims17
A genome editing system for site-directed modification of a target sequence in the genome of a cell, comprising at least one of the following i) to v):
- i) a C2c1 protein or variant thereof, and a guide RNA;
- ii) an expression construct comprising a nucleotide sequence encoding a C2c1 protein or variant thereof, and a guide RNA;
- iii) a C2c1 protein or variant thereof, and an expression construct comprising a nucleotide sequence encoding a guide RNA;
- iv) an expression construct comprising a nucleotide sequence encoding a C2c1 protein or variant thereof, and an expression construct comprising a nucleotide sequence encoding a guide RNA;
- v) an expression construct comprising a nucleotide sequence encoding a C2c1 protein or variant thereof and a nucleotide sequence encoding a guide RNA;
- wherein the guide RNA is capable of forming complex with the C2c1 protein or variant thereof and targeting the C2c1 protein ortholog or variant thereof to the target sequence in the cell genome.
3 more elements
Dependencies are inferred from the claim text.